These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 12041858)

  • 1. Contraceptive methods and risk factors of cardiovascular diseases in Tehranian women: Tehran Lipid and Glucose Study.
    Azizi F; Ainy E; Mirmiran P; Habibian S
    Eur J Contracept Reprod Health Care; 2002 Mar; 7(1):1-6. PubMed ID: 12041858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
    Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
    Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutritional knowledge, attitude and practice of Tehranian adults and their relation to serum lipid and lipoproteins: Tehran lipid and glucose study.
    Mirmiran P; Mohammadi-Nasrabadi F; Omidvar N; Hosseini-Esfahani F; Hamayeli-Mehrabani H; Mehrabi Y; Azizi F
    Ann Nutr Metab; 2010; 56(3):233-40. PubMed ID: 20375546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A longitudinal study of lipids and blood pressure in relation to method of contraception in Latino women with prior gestational diabetes mellitus.
    Xiang AH; Kawakubo M; Buchanan TA; Kjos SL
    Diabetes Care; 2007 Aug; 30(8):1952-8. PubMed ID: 17519432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of routine diabetes and lipid screening after age 35 in candidates for or current users of oral contraceptives.
    Kjos SL; Gregory K; Henry OA; Collins C
    Obstet Gynecol; 1993 Dec; 82(6):925-30. PubMed ID: 8233266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population.
    Morin-Papunen L; Martikainen H; McCarthy MI; Franks S; Sovio U; Hartikainen AL; Ruokonen A; Leinonen M; Laitinen J; Järvelin MR; Pouta A
    Am J Obstet Gynecol; 2008 Nov; 199(5):529.e1-529.e10. PubMed ID: 18533124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study.
    Hadaegh F; Harati H; Ghanbarian A; Azizi F
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):571-7. PubMed ID: 16874147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary heart disease risk factors and menopause: a study in 1980 Tehranian women, the Tehran Lipid and Glucose Study.
    Azizi F; Ainy E
    Climacteric; 2003 Dec; 6(4):330-6. PubMed ID: 15006254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk factors in the elderly: the Tehran Lipid and Glucose Study.
    Azizi F; Emami H; Salehi P; Ghanbarian A; Mirmiran P; Mirbolooki M; Azizi T
    J Cardiovasc Risk; 2003 Feb; 10(1):65-73. PubMed ID: 12569239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lipids, lipoproteins, arterial accidents and oral contraceptives].
    Bakir R; Hilliquin P
    Contracept Fertil Sex (Paris); 1986 Jan; 14(1):81-7. PubMed ID: 12341243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein profile and prevalence of cardiovascular risk factors in urban Moroccan women.
    El ayachi M; Mziwira M; Vincent S; Defoort C; Portugal H; Lairon D; Belahsen R
    Eur J Clin Nutr; 2005 Dec; 59(12):1379-86. PubMed ID: 16118656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Larger hip circumference independently contributed to reduced metabolic risks in Tehranian adult women.
    Esmaillzadeh A; Mirmiran P; Moeini SH; Azizi F
    Int J Cardiol; 2006 Apr; 108(3):338-45. PubMed ID: 15963581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of serum HDL-C level in a Tehran urban population: the Tehran Lipid and Glucose Study.
    Azizi F; Raiszadeh F; Salehi P; Rahmani M; Emami H; Ghanbarian A; Hajipour R
    Nutr Metab Cardiovasc Dis; 2002 Apr; 12(2):80-9. PubMed ID: 12189907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metabolic risks of oral contraception].
    Monier L
    Rev Int Pediatr; 1988 Feb; (178):64-5. PubMed ID: 12282576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of coronary heart disease among Tehran adults: Tehran Lipid and Glucose Study.
    Hadaegh F; Harati H; Ghanbarian A; Azizi F
    East Mediterr Health J; 2009; 15(1):157-66. PubMed ID: 19469439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of cardiovascular risk factors by anthropometric measures in Tehranian adults: receiver operating characteristic (ROC) curve analysis.
    Mirmiran P; Esmaillzadeh A; Azizi F
    Eur J Clin Nutr; 2004 Aug; 58(8):1110-8. PubMed ID: 15280905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the metabolic effects of oral contraceptive and nonhormonal contraceptive use in women over 40 years old.
    Suwikrom S; Jaisamrarn U
    Contraception; 2005 Mar; 71(3):183-7. PubMed ID: 15722067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of different contraceptive methods on the oxidative stress status in women aged 40 48 years from the ELAN study in the province of Liege, Belgium.
    Pincemail J; Vanbelle S; Gaspard U; Collette G; Haleng J; Cheramy-Bien JP; Charlier C; Chapelle JP; Giet D; Albert A; Limet R; Defraigne JO
    Hum Reprod; 2007 Aug; 22(8):2335-43. PubMed ID: 17584753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there an independent association between waist-to-hip ratio and cardiovascular risk factors in overweight and obese women?
    Azizi F; Esmaillzadeh A; Mirmiran P; Ainy E
    Int J Cardiol; 2005 May; 101(1):39-46. PubMed ID: 15860381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.